august 24 2025 glp-1 The Trump Administration's Nov. 6 announcement to significantly reduce the cost of medications marks an important step toward improving access to evidence-based obesity treatment. These medications can support an average 15% Washington Informer | Celebrity voices

Here, we have developed a screening system that enables us to determine the activation of G protein-coupled receptors (GPCRs) by food components and have identified GPR55 as a target for curcumin

These headwinds have led to a sharp decline in its stock price, raising questions about the long-term impact of its gamble.

Tirzepatide is not appropriate for everyone

Did you experience stomach paralysis, gastrointestinal disease, vision loss, or other side effects from Ozempic or Wegovy

It is given as an injection under the skin (subcutaneously), every 2 weeks or once a month

PlexusDx helps patients navigate semaglutide therapy after cholecystectomy with personalized dosing and genetic insights